Other

Change at the top for Biogen after Alzheimer's drug flops

Biogen will replace its CEO and largely abandon marketing of its controversial Alzheimer's drug Aduhelm less than a year after the medication's launch triggered a backlash from experts, doctors and insurers.

Diseases, Conditions, Syndromes

UK virus cases hit new record

The UK on Friday announced a new record number of virus cases fulled by the Omicron variant.

page 6 from 40